Polyclonal Antibody to Dual Adaptor Of Phosphotyrosine And 3-Phosphoinositides (DAPP1)
| Code | Size | Price |
|---|
| PAJ296Mu01-20ul | 20ul | £88.00 |
Quantity:
| PAJ296Mu01-100ul | 100ul | £165.00 |
Quantity:
| PAJ296Mu01-200ul | 200ul | £223.00 |
Quantity:
| PAJ296Mu01-1ml | 1ml | £512.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Mouse
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
BAM32; B lymphocyte adapter protein Bam32; B-cell adapter molecule of 32 kDa; Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Dual Adaptor Of Phosphotyrosine And 3-Phosphoinositides
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-5ug/mL<br/>Immunohistochemistry: 5-20ug/mL<br/>Immunocytochemistry: 5-20ug/mL<br/>Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Dual Adaptor Of Phosphotyrosine And 3-Phosphoinositides (DAPP1) | RPJ296Mu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||